A revenue-generating, small-cap Canadian pharmaceutical company

Revenue Projected at $150,000,000 by 2025

Free
Message: INTERVIEW ALERT: Valeo Pharma (VPH: CSE) (VPHIF: OTCQB)

The interview went very smoothly and the two of them chatted happily. Through the interview, they shared their experiences and lessons with everyone and hope everyone can absorb that useful information. tetris unblocked

Share
New Message
Please login to post a reply